News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Protector post# 267237

Thursday, 06/23/2016 7:09:24 PM

Thursday, June 23, 2016 7:09:24 PM

Post# of 347009
Looks like Peregrine will have control over the final call on these RFP's...

Scientific Review Committees (SRC): The NCCN ORP establishes qualified Scientific Review Committees (SRCs) to conduct the peer review of research proposals received in response to RFPs. SRC members are from NCCN Member Institutions and have expertise in the specific therapeutic areas relevant to the research project. The NCCN ORP SRC review process meets the general NIH standards of peer review and funding by meeting the following three criteria:

the peer review system uses external reviewers and is free of conflict-of-interest
the ranking or rating system in the review process is based on the scientific merit of the proposed research
the funding system is based primarily on the peer review ranking or rating of the research application.

The NCCN ORP requires major reviews by two (2) members of the SRC with discussion and ranking of proposals by all members of the SRC. Grantor representatives serve in an advisory capacity to these committees and are given the opportunity to review each of the proposals prior to the formal review. Grantors may request elimination of particular proposals from scientific review if they duplicate already well-studied concepts or raise safety concerns.

https://www.nccn.org/clinical_trials/research_boards.aspx


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y